Craniotomy Clinical Trial
Official title:
A Retrospective Case Series to Evaluate the Long Term Outcome of the Use of Synthes Patient Specific Implants (PSI®) Made of Polyether Ether Ketone (PEEK) for the Treatment of Cranial Defects in Patients With a Mature Skeleton
The primary objective of this retrospective study is to evaluate the percentage of patients with device related adverse events (infection, rejection, dislocation, fracture of the implant) in the first 24 months after implantation.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | January 2012 |
Est. primary completion date | January 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Males or females age 18 years or over at the time of inclusion into the study - Received a Synthes PSIĀ® made of PEEK intended for replacement of bony voids in the cranial/craniofacial skeleton at least 24 months before inclusion in the study - Ability to obtain written informed consent from the recipient or the recipient's legal guardian - Ability to comply with the procedures described in the protocol, including responding to simple questionnaires either by the recipient in person or by a next relative (spouse, parent) who lives with the recipient Exclusion Criteria: - Patient was contraindicated to receive a PSI made of PEEK at the time of implantation |
Observational Model: Cohort, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
Austria | AKH Allgemeines Krankenhaus | Wien | |
Belgium | Hôpital Erasme ULB | Brussels | |
Chile | Hospital San Pablo de Coquimbo | Coquimbo | |
Chile | Hospital de Trabajador de Santiago | Santiago de Chile | |
Colombia | Hospital San José | Bogotá | |
Colombia | Hospital Universitario San Ignacio | Bogotá | |
Colombia | Instituto Roosevelt | Bogotá | |
Colombia | Hospital Universitario del Valle | Santiago de Cali | |
Costa Rica | Hospital Clinica Biblica | Cartago | |
Czech Republic | University Hospital | Ostrava | |
Denmark | Rigshospital | Copenhagen | |
Finland | Oulu University Hospital | Oulu | |
France | Centre Hospitalier Universitaire | Toulouse | |
Germany | Universitätsklinikum Aachen | Aachen | |
Germany | HELIOS-Klinikum Emil von Behring | Berlin | |
Germany | Universitätsklinikum Düsseldorf | Düsseldorf | |
Germany | Clemenshospital Münster | Heidelberg | |
Germany | Universitätsklinikum Heidelberg | Heidelberg | |
Portugal | Hospital da Universidade | Coimbra | |
Singapore | National Neuroscience Institute | Singapore | |
Spain | Hospital 12 de Octubre | Madrid | |
Spain | Ramon y Cajal Hospital | Madrid | |
Spain | Clinica Universitaria Navarra | Pamplona | |
Switzerland | Inselspital | Bern | |
Switzerland | Hôpital Cantonal Universitaire | Genève | |
Switzerland | Centre Hospitalier Universitaire Vaudois | Lausanne | |
Switzerland | Kantonsspital St- Gallen | St. Gallen | |
Switzerland | Universitätsspital Zürich | Zürich | |
United Kingdom | Queen Victoria Hospital | East Grinstead | |
United Kingdom | The Walton Center | Liverpool |
Lead Sponsor | Collaborator |
---|---|
Synthes GmbH |
Austria, Belgium, Chile, Colombia, Costa Rica, Czech Republic, Denmark, Finland, France, Germany, Portugal, Singapore, Spain, Switzerland, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Device related adverse events | Percentage of patients with the following device related adverse events: infection rejection dislocation fracture |
0-24 months post initial implantation | Yes |
Secondary | Explantation | Explantation, as a result of a device-related adverse event or for another reason | 0 months - study visit at least 24 months after implantation (or scheduled up to 3 months after the study visit) | No |
Secondary | Cosmetic result | Evaluation of the cosmetic result by the surgeon by means of a VAS 0-100, immediately after the surgery or until the patient was discharged from the hospital (any timepoint available) | surgery - at discharge | No |
Secondary | Cosmetic result | Evaluation of the cosmetic result by the surgeon by means of a VAS 0-100, during the study visit, at least 24 months after implantation (see inclusion criteria) | at the study visit, which is at least 24 months after implantation | No |
Secondary | Clinical result | Evaluation of the clinical result by the surgeon by means of a VAS 0-100, immediately after the surgery or until the patient was discharged from the hospital (any timepoint available) | surgery - at discharge | No |
Secondary | Clinical result | Evaluation of the cosmetic result by the surgeon by means of a VAS 0-100, during the study visit, at least 24 months after implantation (see inclusion criteria) | At the study visit, which is at least 24 months after implantation | No |
Secondary | Pressure sensitivity | Evaluation of the pressure sensitivity by the patient (or next of kin appreciation in case of severe disability) by means of a VAS 0-100, during the study visit, at least 24 months after implantation (see inclusion criteria) | At the study visit, which is at least 24 months after implantation | No |
Secondary | Heat / cold sensitivity | Evaluation of the heat/cold sensitivity by the patient (or next of kin appreciation in case of severe disability) by means of a VAS 0-100, during the study visit, at least 24 months after implantation (see inclusion criteria) | At the study visit, which is at least 24 months after implantation | No |
Secondary | Cosmetic result | Evaluation of the cosmetic result by the patient (or next of kin in case of severe disability) by means of a VAS 0-100, during the study visit, at least 24 months after implantation (see inclusion criteria) | At the study visit, which is at least 24 months after implantation | No |
Secondary | Event-free survival | Number of months of event-free survival, in terms of device related adverse events: Infection (superficial and/or deep) [Time frame 0 months - study visit] Rejection of the implant [Time frame 0 months - study visit] Dislocation of the implant [Time frame 0 months - study visit] Fracture of the implant [Time frame 0 months - study visit] |
0 months - at the study visit, which is at least 24 months after implantation | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02880566 -
Efficacy of Scalp Block on Hemodynamic Stability and Opioid Consumption During Craniotomy
|
N/A | |
Completed |
NCT05103735 -
Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
|
||
Completed |
NCT04285359 -
Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
|
||
Completed |
NCT03364283 -
Sitting Versus Horizontal Position on Craniotomies
|
||
Completed |
NCT01502540 -
Pain Prevalence After Major Craniotomy
|
N/A | |
Recruiting |
NCT06157359 -
Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection
|
N/A | |
Recruiting |
NCT01474304 -
Intravenous Acetaminophen for Craniotomy Patients
|
Phase 2 | |
Completed |
NCT01617837 -
The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy
|
Phase 2/Phase 3 | |
Recruiting |
NCT04229966 -
Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
|
||
Completed |
NCT01987648 -
eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome
|
||
Recruiting |
NCT05962684 -
A Greek-designed ERAS Protocol in Elective Craniotomy
|
||
Recruiting |
NCT04261673 -
Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma
|
N/A | |
Completed |
NCT05940935 -
The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
|
||
Completed |
NCT03033706 -
Intraoperative Goal Directed Fluid Management in Supratentorial Brain Tumor Craniotomy
|
N/A | |
Completed |
NCT00658242 -
Craniofacial Surgery Perioperative Registry
|
N/A | |
Completed |
NCT04859907 -
Bone Flap Fixation Systems For Craniotomy Procedures
|
N/A | |
Active, not recruiting |
NCT02237716 -
Rapid Intravenous Infusion of Mannitol Results in a Dipper-type Change in Stroke Volume Variation in Patients Undergoing Major Neurosurgery
|
N/A | |
Recruiting |
NCT01966939 -
Influences of Types of Skull Surgery on Temporomandibular Joint Performance
|
N/A | |
Completed |
NCT01606969 -
Comparison of Epinephrine-lidocaine Solution and Dexmedetomidine -Lidocaine Solution
|
N/A | |
Completed |
NCT00590499 -
Agitation in Post Operative Neurosurgical Patients
|
N/A |